Navigation Links
Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
Date:7/1/2008

A Complimentary Continuing Education Newsletter Series for Healthcare

Professionals

VOORHEES, N.J., July 1 /PRNewswire/ -- Clostridium difficile infection (CDI) is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea to pseudomembranous colitis and death. Recurrent CDI can occur in up to 20% of patients who develop an initial case of CDI.(1) These patients are at increased risk of additional recurrences, as well as more complicated disease, including toxic megacolon, colon perforation, and systemic inflammatory response syndrome with organ failure leading to colectomy or death.

To address the need for education on recurrent CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a 3-part series of complimentary educational newsletters targeted to primary care physicians. Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease is the first newsletter of this series.

The Expert Faculty for this continuing education activity include Ciaran P. Kelly, MD, Associate Professor of Medicine at Harvard Medical School, Director of Gastroenterology Fellowship Training at Beth Israel Deaconess Medical Center, and Chief of Hermann L. Blumgart Internal Medicine, and Vivian G. Loo, MD, MSc, FRCPC, Chief of the Department of Microbiology at McGill University Health Centre.

Healthcare professionals can receive this self-study activity by downloading or ordering online at http://www.rmei.com/CDInewsletters.

Healthcare professionals who treat patients with CDI should take advantage of this opportunity to learn about the management of patients with recurrent CDI.

This continuing education opportunity is jointly sponsored by Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine and
'/>"/>

SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
3. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
4. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
5. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
6. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
7. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
8. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
9. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
10. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
11. APIC Launches Targeting Zero Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Minn. , March 4, 2015   Mayo ... an agreement to develop the next generation of wearable ... "We are hoping that this technology will be game-changer. ... and diabetes," says James Levine, M.D., Ph.D. , ... "They are accurate, inexpensive, and can be integrated into ...
(Date:3/4/2015)... KANSAS CITY, Kan. , March 4, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the licensing, ... animals, today announced that it will present at the ... March 10-12, 2015, at the Loews Miami Beach Hotel ... Steven St. Peter , M.D., President and ...
(Date:3/4/2015)... -- From March 8-11, 2015 Excellis Health Solutions ... and Expo in Orlando, Florida ... education event, attended by nearly 500 manufacturers, distributors, ... distribution industry moving. Attracting thought-provoking speakers, programming puts ... to healthcare distribution and technology, logistics and market ...
Breaking Medicine Technology:Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2
... Support Development,of Omega DUROS Continuous Delivery Therapy, ... Intarcia,Therapeutics, Inc., a privately held biopharmaceutical company,today ... study of omega,interferon with or without ribavirin ... C. The results demonstrate that,omega interferon in ...
... Conn., April 12, 2007 /PRNewswire-FirstCall/ --,CuraGen Corporation ... (PXD101), a histone deacetylase (HDAC) inhibitor being,investigated ... a protein,being investigated for the prevention of ... upcoming American Association for Cancer,Research (AACR) 2007 ...
Cached Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 2CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 3CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 4
(Date:3/4/2015)... York, NY (PRWEB) March 04, 2015 ... WaterAid a total of $6.9 million, which ... Ghana, Mali, Niger and Burkina Faso. , The programs ... areas. The first will focus on fixing water points ... the skills of local people to maintain water points ...
(Date:3/4/2015)... 2015 Nike Swim Camps offer outstanding ... mission is to stimulate a love of swimming in ... provide campers the opportunity to train with some of ... Merrion, Vice President of US Sports Camps. “Our program ... to build confidence and improve their technique.” , Nike ...
(Date:3/4/2015)... Columbus, Ohio (PRWEB) March 04, 2015 ... as an ingredient in premium sports nutrition products, is ... Greatest Trainer booth in the Terrace Ballroom at The ... place from March 5, 2015 to March 8, 2015. ... arginine silicate with FDA New Dietary Ingredient notification status; ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, H1 2015? ... Vasculitis is a disease that features tenderness of the ... not known. Vasculitis can affect any body system and ... include fever, weight loss, tiredness, aches, pains, night sweats, ... Vasculitis is treatable, but it is not curable. The ...
(Date:3/4/2015)... 04, 2015 The week of March ... with World Sleep Awareness Day being recognized on March ... health and financial risks associated with sleep related illnesses, ... Apnea Treatment Centers of America have turned to social ... they hope will virally inspire conversation regarding the disease. ...
Breaking Medicine News(10 mins):Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4
... University of Melbourne have discovered the local action of ... of viral skin infections. , This work identifies previously ... barrier locations such as the skin and the gut, ... bacteria. , Researchers examined two aspects of anti-viral immune ...
... - Portable USB Device Will Expedite Emergency Responders, ... 7 eMed-ID, the world,s first medical identification ... that will expedite emergency responders treatment of trauma ... expanding its national footprint with today,s announcement that ...
... Shamir Optical Industry Ltd. (Nasdaq: SHMR ... technology to the ophthalmic lens market, today announced that the ... that the Company no longer complies with the audit committee ... requires a listed company to have an audit committee of ...
... 7 HIMSS -- Infotech Global, Inc. (IGI) announced ... Health, a not-for-profit health system in Central New Jersey ... Transfer Form (UTF). The draft UTF was tested with ... in 2008. This work was made possible through the ...
... are at risk of developing the eye disease ROP ... from the Sahlgrenska Academy, University of Gothenburg, Sweden, suggests ... for considerably more expensive ophthalmological examinations. , Every year ... months prematurely. Preterm infants are at increased risk of ...
... DARTMOUTH, NS, April 7 /PRNewswire/ - A new study ... AACR (American Association for Clinical Cancer Research), shows diets ... acid) may decrease the risk of prostate cancer. This ... with a genetic tendency towards developing the disease. , ...
Cached Medicine News:Health News:Not just a long-distance relationship: Immune cells in skin fight off infection better than the rest 2Health News:eMed-ID, World's First Medical Identification Franchise, Opens Tampa Bay Market for Franchise Sales 2Health News:eMed-ID, World's First Medical Identification Franchise, Opens Tampa Bay Market for Franchise Sales 3Health News:Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Noncompliance with Nasdaq Audit Committee Composition Requirements 2Health News:Meridian Health Pilots Electronic Transfer Form 2Health News:Meridian Health Pilots Electronic Transfer Form 3Health News:New, simple method identifies preterm infants at risk of eye disease 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 3
... visual field testing that's so efficient it,can ... first visual field instrument that's simple enough, ... used even in pre-test. Affordably priced FDT ... behind it to validate performance. The instrument ...
... Simple operation + Quick results. The ... Operational procedure that create a system of ... reduces patient fatigue, ,Within a compact, ... AP-340 incorporates numerous function and features.The integration ...
... EXCLUDER AAA Endoprosthesis is an innovative device ... option for patients with abdominal aortic aneurysms ... ePTFE bifurcated graft with an outer self-expanding ... flexibility and material durability. The function of ...
... a cast saw to remove a cast from ... in patients. Occasionally patients are cut or burned ... Strip enables healthcare professionals to remove any cast ... provides protection against cuts and burns from the ...
Medicine Products: